Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)
Clinical trial NCT04456699 · COMPLETED
Trial details
- NCT number
- NCT04456699
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2023-03-27
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.